Depression Screening Tools for Patients with Kidney Failure: A Systematic Review
Overview
Affiliations
Background And Objectives: Patients with kidney failure experience depression at rates higher than the general population. Despite the Centers for Medicare and Medicaid Services' ESRD Quality Incentive Program requirements for routine depression screening for patients with kidney failure, no clear guidance exists.
Design, Setting, Participants, & Measurements: For this systematic review, we searched MEDLINE, PsycINFO, and other databases from inception to June 2020. Two investigators screened all abstracts and full text. We included studies assessing patients with kidney failure and compared a tool to a clinical interview or another validated tool (., Beck Depression Inventory II). We abstracted data related to sensitivity and specificity, positive and negative predictive value, and the area under the curve. We evaluated the risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2.
Results: A total of 16 studies evaluated the performance characteristics of depression assessment tools for patients with kidney failure. The Beck Depression Inventory II was by far the best studied. A wide range of thresholds were reported. Shorter tools in the public domain such as the Patient Health Questionnaire 9 and Geriatric Depression Scale 15 (adults over 60) performed well but were not well studied. Short tools such as the Beck Depression Inventory-Fast Screen may be a good option for an initial screen.
Conclusions: There is limited research evaluating the diagnostic accuracy of most screening tools for depression in patients with kidney failure, and existing studies may not be generalizable to US populations. Studies suffer from limitations related to methodology quality and/or reporting. Future research should target widely used, free tools such as the Patient Health Questionnaire 2 and the Patient Health Questionnaire 9.
Clinical Trial Registry Name And Registration Number: Systematic Review Registration: PROSPERO CRD42020140227.
Almutary H, AlShammari N BMC Nephrol. 2025; 26(1):16.
PMID: 39794707 PMC: 11720357. DOI: 10.1186/s12882-025-03950-6.
The utility of brief instruments for depression screening in dialysis patients.
Vazquez I, Figueiras A, Salgado-Barreira A Clin Kidney J. 2025; 18(1):sfae369.
PMID: 39781480 PMC: 11704791. DOI: 10.1093/ckj/sfae369.
Demirhan I, van Oevelen M, Skalli Z, Voorend C, Mooijaart S, Meuleman Y J Nephrol. 2024; 37(7):1939-1948.
PMID: 39327357 PMC: 11519205. DOI: 10.1007/s40620-024-02095-3.
Kubanek A, Renke M, Godlewska B, Paul P, Przybylak M, Kowalska A Front Psychiatry. 2024; 15:1410252.
PMID: 39109362 PMC: 11300368. DOI: 10.3389/fpsyt.2024.1410252.
Alkubati S, Al-Sayaghi K, Salameh B, Halboup A, Ahmed W, J Alkuwaisi M J Multidiscip Healthc. 2024; 17:689-699.
PMID: 38370607 PMC: 10874630. DOI: 10.2147/JMDH.S452935.